Pharmaceuticals

Shingles Vaccine Market Forecast With Insights On Demand And Industry Growth

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Shingles Vaccine Market In 2026, And How Will Its Value Evolve By 2030?

The shingles vaccine market size has witnessed rapid growth in recent years. It is anticipated to increase from $5.55 billion in 2025 to $6.37 billion in 2026, driven by a compound annual growth rate (CAGR) of 14.8%. Historically, this expansion has been primarily due to factors such as the limited availability of shingles vaccines, the reliance on live attenuated vaccines, a growing elderly population, the increasing incidence of herpes zoster, and a rising awareness of the benefits of immunization.

The shingles vaccine market is projected to experience substantial expansion in the coming years, with expectations to reach $10.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. This projected increase is primarily driven by the advancement of recombinant and subunit vaccines, the broadening scope of public and private vaccination efforts, the growing preference for online and retail pharmacy distribution channels, intensified government and healthcare initiatives to immunize the elderly, and the incorporation of digital health monitoring to ensure vaccination compliance. Key developments expected during this period involve a surge in the uptake of recombinant and subunit shingles vaccines, heightened public awareness regarding shingles prevention among older adults, an increase in vaccination program availability through hospitals and retail pharmacies, the expansion of online pharmacies and e-commerce for vaccine distribution, and a strategic emphasis on immunization plans tailored for the population aged 50 and above.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27413&type=smp

Which Drivers Are Supporting The Shingles Vaccine Market Growth?

A growing number of vaccination programs is anticipated to propel the expansion of the shingles vaccine market in the future. These programs are structured public health initiatives designed to systematically administer vaccines to populations, aiming to prevent the spread of infectious diseases. The proliferation of vaccination programs is attributed to increasing awareness of preventive healthcare, motivating more individuals to get vaccinated to avoid illnesses. Such programs improve the adoption of shingles vaccines by elevating public awareness and accessibility, making them particularly suitable for older adults and high-risk demographics. They also reduce the incidence of shingles and its associated complications through the promotion of timely and widespread immunization, thereby improving overall community health. For instance, in July 2025, the World Health Organization, a Switzerland-based Intergovernmental organization, noted that the coverage for the first dose of human papillomavirus (HPV) vaccine in girls climbed from 27% in 2023 to 31% in 2024. Thus, the rising volume of vaccination programs is a significant factor driving the growth of the shingles vaccine market.

How Is The Shingles Vaccine Market Broken Down By Segment Categories?

The shingles vaccine market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine

2) By Product: Shingrix, Zostavax, Skyzoster

3) By Age Group: 50-59 Years, 60-69 Years, 70 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End User: Hospitals, Clinics, Pharmacies

Subsegments:

1) By Live Attenuated Vaccine: Virus Strain A, Virus Strain B, Virus Strain C

2) By Recombinant Vaccine: Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine

3) By Subunit Vaccine: Protein Subunit Vaccine, Conjugate Subunit Vaccine

Which Trends Are Contributing To Changes In The Shingles Vaccine Market?

Leading companies active in the shingles vaccine market are concentrating on developing innovative vaccine formulations, such as recombinant adjuvanted vaccines, to bolster immune response and ensure long-lasting protection against shingles. These recombinant adjuvanted vaccines utilize lab-made viral proteins in conjunction with substances known as adjuvants to enhance the body’s immune response for improved and more enduring protection. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced Shingrix, a shingles vaccine. Shingrix is a non-live, recombinant adjuvanted subunit vaccine administered intramuscularly in two doses for adults aged 50 and above, specifically designed to prevent shingles (herpes zoster) and its related complication, post-herpetic neuralgia. This highly effective vaccine provides over 90% protection against shingles, establishing strong and sustained immunity that lasts at least 10 years, even in older adults and immunocompromised individuals.

Which Players Are Present In The Shingles Vaccine Market Space?

Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc

Get The Full Shingles Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/shingles-vaccine-global-market-report

Which Region Accounts For The Largest Portion Of The Shingles Vaccine Market?

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Shingles Vaccine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/shingles-vaccine-global-market-report

Browse Through More Reports Similar to the Global Shingles Vaccine Market 2026, By The Business Research Company

Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-global-market-report

Folding Furniture Market Report 2026

https://www.thebusinessresearchcompany.com/report/folding-furniture-global-market-report

Foldable Houses Market Report 2026

https://www.thebusinessresearchcompany.com/report/foldable-houses-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795